http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011122859-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5b96b34a4ab4d15cab57156167b7fd7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7eb1035980bb77bc7ccdcf59929a84be http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_38fcab42e3e9220ffadc319903ac51e0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_17c6c7da627b7bead7208250127b52c2 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12 |
| filingDate | 2011-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3e695105b5f79e85936cc7bea3f86c19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fdda6f7c3d6fef21da86b98bf5efac61 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_442b61197a03af5fe1523a4cda72c40a |
| publicationDate | 2011-10-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2011122859-A2 |
| titleOfInvention | Composition for predicting chance of brain tumor recurrence and survival prognosis, and kit containing same |
| abstract | The present invention relates to a method for using genes on chromosome 17p, MYC/MYCN genes and WNT-related genes as marker genes for predicting the risk of brain tumor recurrence and survival prognosis. More specifically, the present invention relates to a method for predicting the risk of brain tumor recurrence and survival prognosis by completely detecting the deletion of genes on chromosome 17p, the increase in expression of MYC/MYCN genes and no increase in expression of WNT-related genes, and a composition and a kit for predicting the risk of brain tumor recurrence and survival prognosis, using the method. Therefore, the present invention can prevent the recurrence of brain tumors by predicting the recurrence of brain tumors including medulloblastoma in advance, and can be effectively used to increase the survival rate of patients with brain tumor recurrence by predicting the survival prognosis of patients that received treatment for brain tumor. |
| priorityDate | 2010-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 408.